Biotech News

The latest biotechnology news and insights Sign up to our newsletter

Newleos Therapeutics Appoints Timothy Noyes as President and CEO

Aarvik Therapeutics Welcomes Laurus Labs as Strategic Investor

Leyden Labs Raises €30M from EIC Fund and Invest-NL for Respiratory Virus Pipeline

Glox Therapeutics Receives Share of £3M CF AMR Syndicate Fund to Combat Lung Infections

Afrigen Biologics Secures $6.2 Million Grant to Develop mRNA Vaccine for Rift Valley Fever

InnoCare Pharma and KeyMed Partner with Prolium Bioscience for Exclusive License Agreement

Micron Biomedical Secures $16M, Boosting Series A to $33M

Be Bio Secures $92M Series C Funding to Advance BCM Therapies

Granata Bio Secures $15M Series A+ to Advance Reproductive Health Innovation

Tune Therapeutics Secures $175M Financing to Accelerate Epigenome Editing Pipeline

Immunis, Inc. Raises $25 Million to Advance IMM01-STEM in Elderly Patients

Ouro Medicines Launches with $120M Funding to Advance Immune Reset Therapies

Windward Bio Launches with $200M Backing to Advance WIN378 for Severe Asthma

A2 Biotherapeutics Secures $80M Series C to Advance Logic-Gated CAR-T Therapies

Timberlyne Therapeutics Secures $180M Series A to Best-in-Class Anti-CD38 Monoclonal Antibody

Leyden Labs Raises $70M to Advance Mucosal Protection Platform

Alesta Therapeutics Secures €65M Series A to Advance Rare Disease Treatments

Vertex Pharmaceuticals Secures FDA Approval for JOURNAVX, a Non-Opioid Pain Treatment

Leveragen and Moonlight Bio Partner to Develop Next-Generation T Cell Therapies

Helicore Biopharma Launches from Stealth Mode with $65M Series A Round

Atalanta Therapeutics Completes $97M Series B Financing to Advance RNAi Therapies

Commit Biologics Secures €5.5M in Extension to Seed Financing

Lutris Pharma Secures $30 Million to Advance Development of LUT014

Orgenesis Secures $5 Million Equity Investement

Lyndra Therapeutics Welcomes Adam Sayer as President and CEO

miRecule Partners with GBI Biomanufacturing to Advance ARC Therapies

Amgen Inaugurates Cutting-Edge Facility in Holly Springs

Alvotech and Teva Announce U.S. FDA Filing Acceptance of Biologics License Applications for AVT05

Ascentage Pharma Raises $126M in Landmark US Biotech IPO

AbbVie Partners with Neomorph to Advance Oncology and Immunology Treatments

Disc Medicine Raises $225.5M, Eyes Bitopertin Commercialisation

Bioxytran Secures $1.6M Investment from TRITON FUNDS to Drive Clinical Trials

Polyrizon Begins GMP Manufacturing for PL-14 Allergy Blocker Ahead of 2025 Clinical Trial

Belhaven Biopharma Secures $11 Million in Funding for Nasdepi Clinical Program and FDA Preparation

ONGENO Secures €3.5 Million to Advance MS Stem Cell Trials

European CDMO Landscape 2025: Download the latest edition